Search research articles
Contact Us
Filters
Showing results (61-70 of 225) with videos related to
Page
of 23
Sort By:
British Journal of Experimental Pathology
|
June 1, 1985
The permeability of normal, adenomatous, ulcerative colitic and malignant large bowel epithelial cell membranes to inulin
T J Chambers, E P Serafini
British Journal of Experimental Pathology
|
February 1, 1986
Human osteoclast-specific antigens are expressed by osteoclasts in a wide range of non-human species
M A Horton, T J Chambers
Endocrinology
|
January 1, 1992
Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2
A M Flanagan, T J Chambers
Journal of Cellular Physiology
|
February 1, 1990
Na+/H+ antiporter is the primary proton transport system used by osteoclasts during bone resorption
T J Hall, T J Chambers
The Journal of Pathology
|
March 1, 1983
Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1
T J Chambers, N N Ali
Bone and Mineral
|
April 1, 1989
Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone
A M Flanagan, T J Chambers
Presse Medicale (Paris, France : 1983)
|
November 23, 1985
[Role of calcitonin in bone]
T J Chambers, J A Darby
Endocrinology
|
October 1, 1986
Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption
P M McSheehy, T J Chambers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 1, 1992
Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells
D A Collins, T J Chambers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1991
Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures
D A Collins, T J Chambers
Page
of 23
Search research articles
Search
Showing results (61-70 of 225) with videos related to
Sort By:
Page
of 23
British Journal of Experimental Pathology
|
June 1, 1985
The permeability of normal, adenomatous, ulcerative colitic and malignant large bowel epithelial cell membranes to inulin
T J Chambers, E P Serafini
British Journal of Experimental Pathology
|
February 1, 1986
Human osteoclast-specific antigens are expressed by osteoclasts in a wide range of non-human species
M A Horton, T J Chambers
Endocrinology
|
January 1, 1992
Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2
A M Flanagan, T J Chambers
Journal of Cellular Physiology
|
February 1, 1990
Na+/H+ antiporter is the primary proton transport system used by osteoclasts during bone resorption
T J Hall, T J Chambers
The Journal of Pathology
|
March 1, 1983
Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1
T J Chambers, N N Ali
Bone and Mineral
|
April 1, 1989
Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone
A M Flanagan, T J Chambers
Presse Medicale (Paris, France : 1983)
|
November 23, 1985
[Role of calcitonin in bone]
T J Chambers, J A Darby
Endocrinology
|
October 1, 1986
Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption
P M McSheehy, T J Chambers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 1, 1992
Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells
D A Collins, T J Chambers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1991
Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures
D A Collins, T J Chambers
Page
of 23